InsidersTradesSigma
Explore the detailed record of transactions filed by Boyle Scott N, Directeur Commercial. Director active across 1 company, notably C4 Therapeutics, Inc.. In total, 2 reports have been recorded. Activity tracked since 26 May 2022. The latest transaction was filed on 26 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Scott N. Boyle is the Chief Business Officer of C4 Therapeutics, Inc. In this role, he is responsible for the company's business strategies and development efforts. With a strong background in the biopharmaceutical industry, he plays a crucial role in expanding operations and establishing strategic partnerships. His leadership contributes to the growth of C4 Therapeutics.